QLSF Biotherapeutics is an innovative immuno-oncology startup company in South San Francisco. We
are focusing on the discovery of next generation antibody-based therapeutics towards high value and
challenging targets for the treatment of cancer. We are dedicated to developing new biologics that
engage the power of the immune system to kill tumor cells. QLSF Biotherapeutics has an experienced
scientific team with expertise in immuno-oncology, antibody discovery, and protein science. We are a
science-driven company, and always welcome scientists with talent and expertise.